Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • New York guideNew York Bids and Bidding Guide
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›New York
  4. ›Healthcare and Medical Services
  5. ›Neuropace Neurostimulators

State University of New York (SUNY)·New York

Neuropace Neurostimulators

Closes 9/29/2026$800k – $2MSole SourceLogin required
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

OSC has granted a single source exemption from advertising for this purchase with Neuropace

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Rachel Hawthorne(Purchase Associate)

[email protected]

(315) 464-2426

Key dates

Opened
9/22/2026
Closes
9/29/2026
Projected award
9/21/2026
Duration
18 months

Last updated

Details

Type
Sole Source
Industry
Healthcare and Medical Services
NAICS
423450
Solicitation №
2139276

Budget estimate

$800,000 – $2,000,000

The solicitation does not disclose a contract value. Neuropace neurostimulators typically range from $15,000 to $30,000 per unit, and a university program of this size could require 20–50 devices over an 18‑month period, plus service contracts and training. Assuming an average unit cost of $22,500 and 30 units, the hardware portion would be roughly $675,000. Adding installation, maintenance, and ancillary services could raise the total to between $800,000 and $2,000,000. Therefore, a reasonable budget estimate for the full contract is $0.8 M–$2 M.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 64%

Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/12/2021

U.S. National Institutes of Health·United States of America

63% match

Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/12/2021

U.S. National Institutes of Health·United States of America

62% match

BRAIN Initiative: Development and Validation of Novel Tools and New Approaches for Neuroscience Research

Closes 6/9/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

61% match

BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2029Opened 8/28/2025

U.S. National Institutes of Health·United States of America

61% match

BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 6/9/2025

U.S. National Institutes of Health·United States of America

60% match

BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)

Closes 6/15/2027Opened 10/23/2024

U.S. National Institutes of Health·United States of America

60% match

Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure ? Clinical Research Sites (U24 Clinical Trial Not Allowed)

Closes 10/31/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

60% match

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System

Closes 1/27/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

60% match

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Closes 6/15/2027Opened 9/25/2024

U.S. National Institutes of Health·United States of America

60% match

BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)

Closes 10/6/2028Opened 5/9/2025

U.S. National Institutes of Health·United States of America

59% match

Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed)

Closes 2/8/2027Opened 9/11/2025

U.S. National Institutes of Health·United States of America

59% match

BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)

Closes 11/8/2027Opened 5/22/2025

U.S. National Institutes of Health·United States of America

59% match

Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure ? Clinical Coordinating Center (CCC) & Data Coordinating Center (DCC)

Closes 10/31/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

59% match

Coordinating Center for National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)

Closes 3/5/2027Opened 1/27/2026

U.S. National Institutes of Health·United States of America

59% match

Limited Competition: BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships

Closes 6/16/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

59% match

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Closes 10/20/2027Opened 10/22/2024

U.S. Department Of Health And Human Services·District of Columbia

58% match

Brain Repair of Any Injured Neural Structure (BRAINS)

Closes 2/26/2027Opened 6/8/2026

U.S. National Institutes of Health·United States of America

58% match

BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)

Closes 1/28/2027Opened 3/19/2024

U.S. National Institutes of Health·United States of America

58% match

BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)

Closes 10/4/2027Opened 8/26/2024

U.S. National Science Foundation·United States of America

58% match

Cognitive Neuroscience (CogNeuro)

Closes 2/1/2027Opened 10/12/2023

U.S. National Institutes of Health·United States of America

58% match

BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed)

Closes 6/23/2028Opened 8/28/2025

NYS Empire State Development·New York

58% match

NeuroCatalyst Commercialization Fund Administrator

Closes 11/18/2026Opened 10/21/2026

U.S. National Institutes of Health·United States of America

58% match

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

Closes 10/20/2027Opened 10/22/2024

U.S. National Institutes of Health·United States of America

58% match

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Closes 8/18/2027Opened 10/1/2024